Irfan Ahsan

Irfan Ahsan

Auto-generated profile, based on publicly available information

Irfan Ahsan

Department of Internal Medicine, Abington Hospital-Jefferson Health, Abington, PA, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 May 2018 in Journal of Community Hospital Internal Medicine Perspectives
Verified
Journal Article
Open access
MHMohsin Hamid
Mohsin Hamid
BLBilal Haider Lashari
Bilal Haider Lashari
IAIrfan Ahsan
Irfan Ahsan
IMIda Micaily
Ida Micaily
USUsman Sarwar
Usman Sarwar
JCJoseph Crocetti
Joseph Crocetti
Methotrexate (MTX) is a chemotherapeutic synthetic(s) phase cell cycle inhibitor, and its role has evolved as an immunological agent in autoimmune diseases like rheumatoid arthritis, psoriasis, and systemic lupus erythematosus, etc. Trimethoprim-sulfamethoxazole (TS) is one of the most widely prescribed antibiotics commonly used for urinary tract infections, exacerbations of chronic bronchitis, traveler's diarrhea, and pneumocystis pneumonia. Both MTX and TS can have significantly overlapping side effects involving dermatologic, renal, and hematological systems, and the combination of these can be deadly. Our case is about the combination of MTX and TS that leads to mucocutaneous ulceration, leukopenia, and renal insufficiency. The purpose of this case is to increase awareness of potentially significant toxicity from the combination of MTX with TS. Abbreviations: MTX: methotrexate; TS: trimethoprim-sulfamethoxazole; ED: emergency department; IV: intravenous; GI: gastrointestinal; NSAIDs: nonsteroidal anti-inflammatory drugs.